Investment news

Natural Cycles, the first app to be CE-certified as a contraceptive in Europe, raised $30 million in a round led by EQT Ventures. Existing investors Sunstone, E-ventures, and Bonnier Growth Media also participated, bringing the company’s total funding to around $38 million.

Milestone on Bayer’s path to completing the planned acquisition of Monsanto

Shandong Weigao Group Medical Polymer Co. agreed to buy closely held Argon Medical Devices Inc. for $850 million, continuing a string of deals by Chinese companies seeking to gain a foothold in the U.S. health-care market.

Medical device maker Teleflex Inc said on Tuesday it would buy privately held NeoTract Inc in its second billion-dollar deal in the past nine months, to strengthen its portfolio of urology devices.

The Trump administration’s plan to slash spending on getting people to sign up for Obamacare will further undermine the law’s already fragile health insurance markets, according to health experts, insurers and people who helped implement the law.

Gilead Sciences Inc agreed to buy Kite Pharma Inc in a nearly $12 billion deal on Monday, as it looks to replace flagging sales from hepatitis C drugs with an emerging and expensive class of cancer immunotherapies that are expected to generate billions of dollars in revenue.

Fosun International Ltd.’s health-care business and Shanghai Pharmaceuticals Holding Co. are among bidders for a stake in U.S. specialty drugmaker Arbor Pharmaceuticals LLC, according to people with knowledge of the matter.

Japan's Mitsubishi Tanabe Pharma Corp (4508.T) has agreed to buy Israeli drug maker Neuroderm (NDRM.O) for $1.1 billion in cash as part of a strategy to grow its business in the United States.